Authors: Pinzani, P Orlando, C Raggi, CC Distante, V Valanzano, R Tricarico, C Maggi, M Serio, M Pazzagli, A

Citation: P. Pinzani et al., Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology, REGUL PEPT, 99(2-3), 2001, pp. 79-86

Authors: Orlando, C Raggi, CC Bagnoni, L Sestini, R Briganti, V La Cava, G Bernini, G Tonini, G Pazzagli, M Serio, M Maggi, M

Citation: C. Orlando et al., Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide, MED PED ONC, 36(1), 2001, pp. 224-226

Authors: Raggi, CC Maggi, M Renzi, D Calabro, A Bagnoni, ML Scaruffi, P Tonini, GP Pazzagli, M De Bernardi, B Bernini, G Serio, M Orlando, C

Citation: Cc. Raggi et al., Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome, J CLIN END, 85(10), 2000, pp. 3866-3873

Authors: Raggi, CC Bagnoni, ML Tonini, GP Maggi, M Vona, G Pinzani, P Mazzocco, K De Bernardi, B Pazzagli, M Orlando, C

Citation: Cc. Raggi et al., Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system, CLIN CHEM, 45(11), 1999, pp. 1918-1924